Life science project management software for pharma, biotech and medtech teams

It manages the planning, delivery and governance of R&D programs, clinical research, drug development and medical device projects in a single system. Unlike generic work management tools, it handles stage gates, regulatory documentation and compliance tracking alongside schedules, budgets and resources. Biotech project management software of this kind connects portfolio decisions to the people and money needed to deliver them. antaivo does that across pharmaceuticals, biotechnology, diagnostics and medical devices.

The five disciplines are scope definition, schedule control, cost and resource control, risk management and regulatory compliance. In regulated work, a single error in process or documentation can delay a submission by months, so all five need to work from the same data. antaivo supports them in a single platform, so teams don’t switch between tools to keep scope, time, cost, risk and compliance aligned.

Yes, at program and portfolio level. antaivo tracks study timelines, site activation milestones, enrollment progress and risk, and links trial milestones directly to budget forecasts and resource plans. Day-to-day trial operations, such as site monitoring and patient data, usually run in a CTMS and EDC. antaivo sits above them, so leaders can see how every study affects the pipeline, the budget and the people available.

QMS workflows, CAPA tracking, audit trails and documentation controls for FDA and EMA requirements are built into the platform. Every action that affects a regulated deliverable is logged with the time, date and user. Compliance tracking happens inside the same system as the work, so teams don’t maintain a separate documentation process.

Yes. antaivo maps stage-gate R&D portfolios with benefit scoring, risk scoring and probability-of-success analysis. Portfolio leaders see the full pipeline in one view, compare scenarios across programs and reallocate resources when priorities shift. See effective project prioritization in biopharma for more.

Common KPIs include time to IND or NDA filing, clinical cycle times, enrollment velocity, cost variance, EAC accuracy and milestone achievement. antaivo tracks them in real time and flags early warnings when performance moves off plan. For drug development teams, catching a problem early can be the difference between hitting and missing a submission window. Genentech reduced time to market by 10% with Cora.

antaivo supports role- and skill-based capacity planning across clinical, regulatory and manufacturing teams. Resource management shows where experienced people are over-allocated, highlights skills gaps before they affect delivery, and lets leaders test the resource effect of starting a new research program. Specialist knowledge is hard to find, so antaivo helps deploy it with precision rather than guesswork.

Yes. Post-market surveillance (PMS), post-market clinical follow-up (PMCF), complaint handling and vigilance tracking can run in the same framework used for development. Medical device companies have ongoing regulatory requirements after launch, and this keeps quality and regulatory teams on a consistent process for the full product lifecycle.

Yes. antaivo supports multi-region scheduling, localization, multiple currencies and configurable regional compliance frameworks for global clinical trials and pharmaceutical development. Multinational pharma and biotech organizations can manage a single global portfolio without losing local compliance detail.

A clinical trial management system (CTMS) runs trial operations: sites, monitoring visits, patient enrollment, investigator payments and study documents. Clinical trial management software from vendors such as Veeva Systems, IQVIA and Medidata is widely used for this. Portfolio software works one level up: it decides which studies and programs to fund, plans resources across them and tracks budgets, risks and milestones for the whole pipeline. Many sponsors run both, with trial management software for operations and antaivo for portfolio control.

Veeva Systems provides cloud software for clinical, regulatory, quality and commercial operations, and IQVIA combines clinical research services with technology and data. Both are central to many sponsors’ trial and regulatory work. antaivo doesn’t replace them; it manages the portfolio, budgets, resources and governance that span all studies and programs, and can draw milestone and status data from operational systems through integration.

LabArchives is an electronic lab notebook (ELN) used to record experiments and research data, and LIMS platforms manage samples and lab workflows. These tools hold the science. antaivo handles research management above them: which research programs are funded, who works on them, what they cost and how they move through stage gates. Linking the two gives leaders a clear view from discovery to development.

Asana markets templates for clinical trial work, and Smartsheet or Jira are common in research teams for tracking tasks. These work management tools are flexible and quick to set up. They usually lack stage-gate governance, audit trails for regulated deliverables, portfolio-level financials and skill-based capacity planning. Teams often keep them for day-to-day tasks while the portfolio runs in a platform such as antaivo.

The best pharmaceutical project management software connects strategy, science and spend. Look for these features:

• Stage-gate governance with audit trails for regulated deliverables.

• Portfolio scoring with probability of success and scenario comparison.

• Skill-based capacity planning across clinical, regulatory and manufacturing teams.

• Budgets, forecasts and EAC linked to each program.

• Supplier and CRO management.

• Integration with CTMS, ELN, LIMS, QMS and ERP systems.

• Cloud deployment with strong data security.

Cora customers include Genentech, Elanco and Boston Scientific.

Companies across pharmaceuticals, biotechnology and diagnostics use several categories of life sciences software: a CTMS and EDC for trials, an ELN and LIMS for research, a QMS for quality, regulatory information management, ERP for finance and supply chain, and portfolio and program management for R&D and capital projects. Veeva, IQVIA, Medidata, LabArchives, SAP and antaivo are widely used across these categories.

The largest makers of life science tools, meaning laboratory instruments, reagents and consumables, include Thermo Fisher Scientific, Danaher, Agilent Technologies, Illumina, Merck KGaA (MilliporeSigma in the US) and Bio-Rad. Software for life sciences comes from a different group of companies, including Veeva, IQVIA, Medidata (Dassault Systèmes) and portfolio platforms such as antaivo.

antaivo runs in the cloud, with on-premises options for organizations that need them. Integration with ERP platforms such as SAP, Oracle and Workday brings financial and workforce data into the portfolio, and connections to clinical, quality and research systems bring milestone and status data in. See integrations for the current list.

Most sponsors outsource parts of clinical research to contract research organizations (CROs) and third-party manufacturers. antaivo’s supplier management tracks contracts, payments and deliverables for each partner, and links them to study milestones and submission timelines. When a CRO deliverable slips, the effect on the program is visible straight away.

The five basic phases are initiation, planning, execution, monitoring and control, and closing. In regulated R&D, each phase includes governance steps: stage gates at initiation, regulatory planning, controlled execution, compliance monitoring and documented closeout. antaivo supports each phase with templates, approvals and audit trails.

Yes. Several tools offer free plans, including Trello, Asana’s basic plan and ClickUp, and open-source tools such as OpenProject are free to self-host. Free tools suit small teams with simple tasks. They don’t usually include regulated audit trails, stage-gate governance or portfolio financials, which pharma and biotech organizations need once programs carry regulatory and investment risk.

Yes. Microsoft offers Microsoft Project for detailed scheduling and Microsoft Planner for team task tracking, both available through Microsoft 365. They suit individual projects and teams. Portfolio decisions across a regulated R&D pipeline usually need a dedicated platform; antaivo works alongside Microsoft tools and integrates with Microsoft 365 for collaboration.

Most portfolio reviews rely on asking for status, waiting, consolidating and presenting. Elanco’s portfolio lead described how pulling the information together once took weeks of emails and spreadsheets. By then the status has moved on. antaivo’s AI watches programs continuously and surfaces what matters as it happens: a study milestone slipping, a regulatory specialist double-booked, a budget drifting. Each signal comes with the cause named and a fix drafted. Cora calls this surfaced, not discovered.

No. In Cora’s approach, agents propose, people approve, and every action is recorded. Data doesn’t change because a model decided it should, and auditors can see who approved each change and why. For GxP and other regulated work, that audit trail is what makes AI usable. As Cora founder and CEO Philip Martin puts it, “AI you can’t audit is a rumor with a confidence score.”